Genentech Inc. of South San Francisco completed its purchase of Biogen Idec’s biologics manufacturing facility in Oceanside for $408 million, or about $816 per square foot.
Genentech Inc. of South San Francisco completed its purchase of Biogen Idec’s biologics manufacturing facility in Oceanside for $408 million, or about $816 per square foot.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
1 Antibody Way, Oceanside, CA